Organisation paid for research Program year 2025 Source: CMS Open Payments

PCRS Network, LLC

Neither a doctor nor a teaching hospital

Research payments

$162,736

105 payments

Through program year 2025, PCRS Network, LLC is reported as receiving $162,736 in research payments, across 105 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $33,789 20
2024 Research $106,724 80
2023 Research $15,468 3
2019 Research $6,755 2

Breakdown

Who paid Research payments · program years 2019–2025
  1. Dompe Farmaceutici S.p.A. $155,981 103 payments
  2. AbbVie, Inc. $5,000 1 payment
  3. American Regent $1,755 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 and other community-acquired pneumonia. A multinational, multicentre, randomised, double-blinded, placebo-controlled, parallel-group phase III trial. (REPAVID-22) $155,981 103 payments
  2. M16-383 $5,000 1 payment
  3. 1Vit17044 $1,755 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record